Index Investing News
Sunday, August 31, 2025
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

Sanofi stock rises as Dupixent shows benefit in lung disease smokers, meets phase 3 goals

by Index Investing News
March 23, 2023
in Financial
Reading Time: 2 mins read
A A
0
Home Financial
Share on FacebookShare on Twitter


JHVEPhoto

Sanofi (NASDAQ:SNY) and Regeneron Pharmaceuticals’ (NASDAQ:REGN) Dupixent met the main goal and all key secondary goals of a phase 3 trial to treat adults who were current or former smokers with chronic obstructive pulmonary disease (COPD).

The French pharma giant said Dupixent (dupilumab) showed the potential to become the first biologic to treat COPD by showing significant reduction in exacerbations in trial.

The late stage study, dubbed BOREAS, enrolled 939 adults, who were current or former smokers aged 40 to 80 years with moderate-to-severe COPD and evidence of type 2 inflammation. The patients received Dupixent (n=468) or placebo (n=471), added to maximal standard-of-care inhaled therapy (triple therapy). BOREAS is one of two trials in the Dupixent COPD program.

Patients on Dupixent experienced, 30% reduction in moderate or severe acute COPD exacerbations over 52 weeks, which was the main goal of the trial.

Sanofi said Dupixent is the first and only biologic to demonstrate clinically meaningful and statistically significant reduction in exacerbations compared to placebo.

In addition, the company said Dupixent is the first and only biologic to show rapid and significant improvement in lung function.

Patients receiving Dupixent showed improved lung function from baseline by 160 mL at 12 weeks compared to 77 mL for placebo, with the benefit compared to placebo sustained through week 52, both of which were key secondary goals of the study according to the company.

Dupixent also showed improvements in quality of life and respiratory symptoms of COPD, according to the company.

“We took a bold approach with our direct to Phase 3 program, shaving years off standard clinical development timelines. We are excited to share these unprecedented and potentially paradigm-shifting clinical results, which may give new hope to patients, caregivers and physicians,” said Dietmar Berger, head of Global R&D ad interim and chief medical officer at Sanofi.

The company said safety was generally consistent with the known safety profile of Dupixent. Overall rates of adverse events (AEs) were 77% for Dupixent and 76% for placebo.

The companies plan to share the results with results with regulatory authorities.

COPD is a respiratory disease which damages the lungs and causes progressive lung function decline. Smoking is a key risk factor for COPD, but even people who quit smoking can still develop the disease, according to the company.

SNY +6.39% to $51.91 premarket March 23



Source link

Tags: benefitdiseaseDupixentGoalslungmeetsPhaseRisesSanofishowssmokersStock
ShareTweetShareShare
Previous Post

Lean Times Require Real Estate Pros To Lean In. Here’s How

Next Post

TikTok CEO testifying before Congress Thursday

Related Posts

UK bars Israeli gov’t officers from DSEI protection exhibition

UK bars Israeli gov’t officers from DSEI protection exhibition

by Index Investing News
August 31, 2025
0

The British authorities has determined to limit the official participation of Israeli authorities and navy representatives on the DSEI...

Banks To Stay Closed For 15 Days, Test Full Checklist

Banks To Stay Closed For 15 Days, Test Full Checklist

by Index Investing News
August 27, 2025
0

Sept. 3 – Karma Puja vacation in JharkhandSept. 4 – First Onam vacation in KeralaSept. 5 – Id-E-Milad/Milad-un-Nabi or Id-e...

Modernise transport legal guidelines – The Hindu BusinessLine

Modernise transport legal guidelines – The Hindu BusinessLine

by Index Investing News
August 27, 2025
0

Digital invoice of lading can guarantee price effectivity, sustainability and transparency in international maritime commerce | Picture Credit score: Suphanat...

Artisan Small Cap Fund Bought Freshworks (FRSH) Attributable to Issues Over the Effectiveness of AI Transition

Artisan Small Cap Fund Bought Freshworks (FRSH) Attributable to Issues Over the Effectiveness of AI Transition

by Index Investing News
August 26, 2025
0

Artisan Companions, an funding administration firm, launched its “Artisan Small Cap Fund” second-quarter 2025 investor letter. A replica of the...

Who’s ”Miss Atomic Bomb”? Historian looked for 25 years for reply

Who’s ”Miss Atomic Bomb”? Historian looked for 25 years for reply

by Index Investing News
May 31, 2025
0

It wasn't going to be simple to trace down the lady who got here to be often called "Miss Atomic...

Next Post
TikTok CEO testifying before Congress Thursday

TikTok CEO testifying before Congress Thursday

Jewel Claims Her Mom Embezzled Over 0 Million of Her Money, Left Her  Mil in Debt

Jewel Claims Her Mom Embezzled Over $100 Million of Her Money, Left Her $3 Mil in Debt

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

This is Why Technical Chart Hints Bitcoin (BTC) Might Lose 750 Help

This is Why Technical Chart Hints Bitcoin (BTC) Might Lose $20750 Help

August 26, 2022
How A lot Cash She Makes – Hollywood Life

How A lot Cash She Makes – Hollywood Life

October 23, 2024
Creating a Successful YouTube Strategy: A Step-by-Step Guide

Creating a Successful YouTube Strategy: A Step-by-Step Guide

January 16, 2024
Meta Platforms Stock: Solid Technicals And Deeply Undervalued

Meta Platforms Stock: Solid Technicals And Deeply Undervalued

January 14, 2023
California sues big oil companies, claiming decades of deception on climate harm

California sues big oil companies, claiming decades of deception on climate harm

September 17, 2023
Capella Commercial aims to create a destination south of Austin with Project Two Step

Capella Commercial aims to create a destination south of Austin with Project Two Step

February 13, 2024
Chinese language share buybacks soar to file excessive

Chinese language share buybacks soar to file excessive

October 21, 2024
2023 Fisker Ocean EV – The Big Picture

2023 Fisker Ocean EV – The Big Picture

March 5, 2023
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In